Treatment of ventilator-associated pneumonia with piperacillin-tazobactum and amikacin vs cefepime and levofloxacin: A randomized prospective study

Indian Journal of Critical Care Medicine

Volumn 11, Issue 3, 2007, Pages 117-121

  Ahmed, S ^a   Choudhary, J ^a   Ahmed, M ^a   Arora, V ^a   Parul, ^a   Ali, S ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Antibiotics; Cefepime; Levofloxacin; Piperacillin tazobactam; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC THERAPY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 35148839885     PISSN: 09725229     EISSN: None     Source Type: Journal    
DOI: 10.4103/0972-5229.35084     Document Type: Article

References (16)

1. Papazian L, Bregeon F, Thirion X, Gregoire R, Saux P, Denis JP, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996;154:91-7.
2. Rello J, Quintana E, Ausina V, Castella J, Luquin M, Net A, et al. Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991;100:439-44.
3. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia study group. Intensive Care Med 1996;22:387-94.
4. Dunagan, WC, Woodward RS, Medoff G, Gray JL, Casabar E, Lawrenz C, et al. Antibiotic misuse in two clinical situations: Positive blood cultures and administration of aminoglycoside. Rev Infect Dis 1991;13:405-12.
5. Gruson D, Hilbert G, Vargas F, Valentino R, Bebear C, Allery A, et al. Rotation and restricted use of antibiotics in a Medical Intensive care unit. Am J Respir Crit Care Med 2000;162:837-43.
6. Fowler RA, Flavin KE, Barr J, Weinacker AB, Parsonnet J, Gould MK. Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest 2003;123:835-44.
7. Mathai D, Rhomberg PR, Biedenbach DJ, Jones RN; India Antimicrobial Resistance Study Group. Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial gents tested against recent clinical isolates from India: A survey of ten medical center laboratories. Diag Microbiol Infect Dis 2002;44:367-77.
8. Fish DN, Choi MK, Jung R. Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs. J Antimicrob Chemother 2002;50:1045-9.
9. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-74.
10. Fink MP, Snydman DR, Niederman MS, Leeper KV, Johnson RH, Heard SO, et al. Treatment of severe Pneumonia in hospitalized patients: Results of multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastin. Antimicrob Agents Chemother 1994;38:547-57.
11. Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H, et al. Monotherapy vs β-lactam-aminoglycoside combination treatment for Gram-negative bacteremia: A prospective, observational study. Antimicrob Agents Chemother 1997;41:1127-33.
12. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1995;153:1711-25.
13. Lynch JP. Hospital-acquired pneumonia: Risk-factors, microbiology and treatment. Chest 2001;119:373S-84S.
14. Kessler RE. Cefepime microbiologic profile and update. Pediatr Infect Dis J 2001;20:331-6.
15. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, et al. Incidence and risk factors for ventilator associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-40.
16. Cook DJ, Kollef MH. Risk factors for ICU-acquired pneumonia. JAMA 1998;279:1605-6.